- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06136234
Caring for Vets and Service Members: Caring Contacts for Stressed and Distressed Veterans and Service Members (COVE)
COVE (Caring for Vets and Service Members)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to evaluate whether Caring Contacts via text message are beneficial to veterans and service members experiencing stress or distress. In the past, Caring Contacts interventions have focused on individuals who are already suicidal and not a more general population. In addition, a core objective of this study is to understand the mechanisms of action of Caring Contacts and thus has included an ecological momentary assessment (EMA) component that will allow us to determine when and how Caring Contacts is making an impact.
Study aims are to
Evaluate if stressed or distressed veterans receiving Caring Contacts are at greater or less risk of suicidal ideation or behavior as evidenced by:
Decreased mean and reduction in variability of indicators of suicide risk (motivation to live, passive ideation, active ideation, suicide intent, and urges to harm self) acquired during Ecological Momentary Assessment periods.
Reduced risk of suicidal ideation (HASS-I) and cognitions (SCS-R) during follow-up.
Examine diverse veterans' experiences with Caring Contacts (i.e., access, satisfaction, preferences, potential mechanisms)
Evaluate if veterans receiving Caring Contacts will show a decrease in distress (i.e., isolation, depression, substance use, loneliness, defeat, hopelessness, and psychological pain)
Identify potential mechanisms of action for Caring Contacts by exploring the relationship between potential mechanisms (i.e., mattering, connectedness, social responsibility, and entrapment), distress, and suicide risk observed during ecological momentary assessment periods to identify potential mechanisms of action of Caring Contacts on decreasing distress and suicide risk
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- University of Washington
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- US service member or veteran
- 18 years or older
- Lives in the United States
- Stressed (recent separation from or in transition out of the military, unemployment, financial strain, unhoused, or suicide loss, etc.) or distressed (isolation, depression, substance use, loneliness, defeat, hopelessness, psychological pain, or suicidal ideation, etc.)
- Willingness to be contacted periodically by text message and either email or postal mail
Exclusion Criteria:
- Unable to consent due to inability to understand the consent form due to cognitive limitations or insufficient English (as determined by inability to pass the consent quiz items)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Condition with intensive assessment
Caring Contacts plus best available resources, with monthly EMAs during study year
|
Caring Contacts are brief, periodic messages sent over 1 year that express unconditional care and concern
Participants will be offered information about best available resources and will receive an email summarizing the resources with links and contact information.
These resources are tailored to best serve the participant based on information they share during the online survey or during conversations with study staff.
|
|
Active Comparator: Control Condition with intensive assessment
Best available resources, with monthly EMAs during study year
|
Participants will be offered information about best available resources and will receive an email summarizing the resources with links and contact information.
These resources are tailored to best serve the participant based on information they share during the online survey or during conversations with study staff.
|
|
Experimental: Experimental Condition without intensive assessment
Caring Contacts plus best available resources, without monthly EMAs during study year
|
Caring Contacts are brief, periodic messages sent over 1 year that express unconditional care and concern
Participants will be offered information about best available resources and will receive an email summarizing the resources with links and contact information.
These resources are tailored to best serve the participant based on information they share during the online survey or during conversations with study staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicidal Ideation
Time Frame: Baseline and 12 month follow-up
|
Harkavy-Asnis Suicide Scale (HASS-I), adapted version for study procedures.
Min=0, max=60, higher scores indicate higher suicidal ideation.
|
Baseline and 12 month follow-up
|
|
Suicide Cognitions
Time Frame: Baseline and 12 month follow-up
|
Suicide Cognitions Scale - Revised, Min=16, max=80, higher scores indicate more suicidal cognitions.
|
Baseline and 12 month follow-up
|
|
Suicide risk Visual Analog Scales (VAS)
Time Frame: 3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
Suicide risk indicators rated on Visual Analog Scales (VAS; 0-10) acquired during Ecological Momentary Assessment periods.
Core constructs of suicide risk selected and worded to maximize face validity: motivation to live, passive ideation, active ideation, and urges for suicide.
Higher scores indicate higher suicidal risk (motivation to live is reverse coded).
|
3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Experience of receiving Caring Contacts
Time Frame: 12 month follow-up
|
Participants will be asked to describe their experiences with Caring Contacts via an online survey and a qualitative interview with a subset of participants
|
12 month follow-up
|
|
Depression
Time Frame: Baseline and 12 month-up
|
Patient Health Questionnaire-9 (PHQ-9), Min=0, max=30, higher scores indicate higher degree of depression severity.
|
Baseline and 12 month-up
|
|
Substance Abuse
Time Frame: Baseline and 12 month follow-up
|
Short Inventory of Problems - Alcohol and Drugs (SIP-AD)
|
Baseline and 12 month follow-up
|
|
Loneliness
Time Frame: Baseline and 12 month follow-up
|
NIH Loneliness Scale, Min=5, max=25, higher scores indicate increased loneliness.
|
Baseline and 12 month follow-up
|
|
Defeat
Time Frame: Baseline and 12 month follow-up
|
The Defeat Scale, Min=0, max=64, higher scores indicate greater defeat.
|
Baseline and 12 month follow-up
|
|
Hopelessness
Time Frame: Baseline and 12 month follow-up
|
Beck's Hopelessness Scale (BHS), Min=0, max=20, higher scores indicate greater hopelessness.
|
Baseline and 12 month follow-up
|
|
Psychological Pain
Time Frame: Baseline and 12 month follow-up
|
Unbearable Psychache Scale-3 (UPS-3), Min=3, max=15, higher scores indicate greater psychological pain.
|
Baseline and 12 month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Potential Mechanism: Entrapment
Time Frame: 3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
A single item, "I feel trapped," acquired during Ecological Momentary Assessment periods.
Min=1, max=7, higher score indicates increased feelings of entrapment.
|
3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
|
Potential Mechanism: Personal and Social Responsibility
Time Frame: 3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
Responsibility Scale acquired during Ecological Momentary Assessment periods.
Min=8, max=40, higher scores indicate greater sense personal and social responsibility.
|
3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
|
Potential Mechanism: Mattering
Time Frame: 3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
General Mattering Scale acquired during Ecological Momentary Assessment periods.
Min=5, max=20, higher scores indicate greater sense of mattering.
|
3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
|
Potential Mechanism: Perceived Burdensomeness
Time Frame: 3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
A single item, "I felt that I was a burden to other people, or that they would be better off without me," acquired during Ecological Momentary Assessment periods.
Min=1, max=7, higher score indicates increased feelings of burdensomeness.
|
3 EMA assessments/day for 14 days at baseline; then either 3 EMA assessments/day for 7 days at 12 months OR 3 EMA assessments/day for 7 days/month for 12 months (depending on EMA condition)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine A Comtois, PhD/MPH, University of Washington
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00019011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustNot yet recruitingOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
Clinical Trials on Caring Contacts
-
St. Luke's Health System, Boise, IdahoUniversity of Washington; American Foundation for Suicide Prevention; Idaho Crisis...Active, not recruitingSuicide | Suicide and Self-harm | Suicide PreventionUnited States
-
Sunnybrook Health Sciences CentreCompletedPsychiatric HospitalizationCanada
-
Butler HospitalMichigan State UniversityCompletedSuicide and Self-harmUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoNational Institute of Mental Health (NIMH)Not yet recruitingSuicide PreventionUnited States
-
St. Luke's Health System, Boise, IdahoPatient-Centered Outcomes Research Institute; University of Washington; Idaho...CompletedCovid19 | Mental HealthUnited States
-
Washington State UniversityNational Institute of Mental Health (NIMH); University of WashingtonActive, not recruitingSuicidal Ideation | Suicide, AttemptedUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)CompletedDepression | Suicidal Ideation | Suicide | Mental Health Impairment | SuicidalUnited States
-
VA Office of Research and DevelopmentCompletedLonelinessUnited States
-
Johns Hopkins Bloomberg School of Public HealthNational Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver...CompletedAnxiety | Depressive Symptoms | Mental Health IssueUnited States
-
St. Luke's Health System, Boise, IdahoPatient-Centered Outcomes Research Institute; University of Pennsylvania; Columbia... and other collaboratorsActive, not recruitingAdolescent | Depressive Disorder | Depression | Suicidal Ideation | Suicide, Attempted | Suicide | Mental Health | Loneliness | Social Support | Mental Disorder | Outpatients | Ambulatory Care | Continuity of Patient Care | Adult | Secondary Prevention | Emergency Service, Hospital | Mental Health Services | Patient Care Planning and other conditionsUnited States